Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1705 to 1715 of 1715 entries
Sorted by: Best Match Show Resources per page
Diagnosis of Classic Homocystinuria in Two Boys Presenting with Acute Cerebral Venous Thrombosis and Neurologic Dysfunction after Normal Newborn Screening.

International journal of neonatal screening

Asamoah A, Wei S, Jackson KE, Hersh JH, Levy H.
PMID: 34449521
Int J Neonatal Screen. 2021 Jul 23;7(3). doi: 10.3390/ijns7030048.

Homocystinuria, caused by cystathionine β-synthase deficiency, is a rare inherited disorder involving metabolism of methionine. Impaired synthesis of cystathionine leads to accumulation of homocysteine that affects several organ systems leading to abnormalities in the skeletal, cardiovascular, ophthalmic and central...

Cite
Asamoah A, Wei S, Jackson KE, et al. Diagnosis of Classic Homocystinuria in Two Boys Presenting with Acute Cerebral Venous Thrombosis and Neurologic Dysfunction after Normal Newborn Screening. Int J Neonatal Screen. 2021;7(3)doi: 10.3390/ijns7030048.
Asamoah, A., Wei, S., Jackson, K. E., Hersh, J. H., & Levy, H. (2021). Diagnosis of Classic Homocystinuria in Two Boys Presenting with Acute Cerebral Venous Thrombosis and Neurologic Dysfunction after Normal Newborn Screening. International journal of neonatal screening, 7(3), . https://doi.org/10.3390/ijns7030048
Asamoah, Alexander, et al. "Diagnosis of Classic Homocystinuria in Two Boys Presenting with Acute Cerebral Venous Thrombosis and Neurologic Dysfunction after Normal Newborn Screening." International journal of neonatal screening vol. 7,3 (2021). doi: https://doi.org/10.3390/ijns7030048
Asamoah A, Wei S, Jackson KE, Hersh JH, Levy H. Diagnosis of Classic Homocystinuria in Two Boys Presenting with Acute Cerebral Venous Thrombosis and Neurologic Dysfunction after Normal Newborn Screening. Int J Neonatal Screen. 2021 Jul 23;7(3). doi: 10.3390/ijns7030048. PMID: 34449521; PMCID: PMC8395908.
Copy Download .nbib Format: NLM
HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Wieland A, Etzion O, Ali RO, Levy E, Kleiner DE, Helmke SM, Heller T, Everson GT.
PMID: 33895359
Clin Gastroenterol Hepatol. 2021 Apr 22; doi: 10.1016/j.cgh.2021.04.030. Epub 2021 Apr 22.

Physicians use portal pressure measurements in clinical practice and research but the methods are invasive, can cause complications, and are resource intensive.

Cite
Wieland A, Etzion O, Ali RO, et al. HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease. Clin Gastroenterol Hepatol. 2021;doi: 10.1016/j.cgh.2021.04.030.
Wieland, A., Etzion, O., Ali, R. O., Levy, E., Kleiner, D. E., Helmke, S. M., Heller, T., & Everson, G. T. (2021). HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . https://doi.org/10.1016/j.cgh.2021.04.030
Wieland, Amanda, et al. "HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. (2021). doi: https://doi.org/10.1016/j.cgh.2021.04.030
Wieland A, Etzion O, Ali RO, Levy E, Kleiner DE, Helmke SM, Heller T, Everson GT. HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease. Clin Gastroenterol Hepatol. 2021 Apr 22; doi: 10.1016/j.cgh.2021.04.030. Epub 2021 Apr 22. PMID: 33895359; PMCID: PMC8531144.
Copy Download .nbib Format: NLM
REPLY.

Hepatology (Baltimore, Md.)

John BV, Dahman B, Taddei TH, Levy C, Kaplan DE.
PMID: 33942361
Hepatology. 2021 Oct;74(4):2308. doi: 10.1002/hep.31876. Epub 2021 Jul 20.

No abstract available.

Cite
John BV, Dahman B, Taddei TH, et al. REPLY. Hepatology. 2021;74(4):2308doi: 10.1002/hep.31876.
John, B. V., Dahman, B., Taddei, T. H., Levy, C., & Kaplan, D. E. (2021). REPLY. Hepatology (Baltimore, Md.), 74(4), 2308. https://doi.org/10.1002/hep.31876
John, Binu V, et al. "REPLY." Hepatology (Baltimore, Md.) vol. 74,4 (2021): 2308. doi: https://doi.org/10.1002/hep.31876
John BV, Dahman B, Taddei TH, Levy C, Kaplan DE. REPLY. Hepatology. 2021 Oct;74(4):2308. doi: 10.1002/hep.31876. Epub 2021 Jul 20. PMID: 33942361; PMCID: PMC8463416.
Copy Download .nbib Format: NLM
Highly efficient multiplex genetic engineering of porcine primary fetal fibroblasts.

Surgery open science

Klapholz B, Levy H, Kumbha R, Hosny N, D'Angelo ME, Hering BJ, Burlak C.
PMID: 33937740
Surg Open Sci. 2020 Nov 18;4:26-31. doi: 10.1016/j.sopen.2020.11.003. eCollection 2021 Apr.

BACKGROUND: Genetically engineered porcine donors are a potential solution for the shortage of human organs for transplantation. Incompatibilities between humans and porcine donors are largely due to carbohydrate xenoantigens on the surface of porcine cells, provoking an immune response...

Cite
Klapholz B, Levy H, Kumbha R, et al. Highly efficient multiplex genetic engineering of porcine primary fetal fibroblasts. Surg Open Sci. 2020;4:26-31doi: 10.1016/j.sopen.2020.11.003.
Klapholz, B., Levy, H., Kumbha, R., Hosny, N., D'Angelo, M. E., Hering, B. J., & Burlak, C. (2021). Highly efficient multiplex genetic engineering of porcine primary fetal fibroblasts. Surgery open science, 426-31. https://doi.org/10.1016/j.sopen.2020.11.003
Klapholz, Benjamin, et al. "Highly efficient multiplex genetic engineering of porcine primary fetal fibroblasts." Surgery open science vol. 4 (2021): 26-31. doi: https://doi.org/10.1016/j.sopen.2020.11.003
Klapholz B, Levy H, Kumbha R, Hosny N, D'Angelo ME, Hering BJ, Burlak C. Highly efficient multiplex genetic engineering of porcine primary fetal fibroblasts. Surg Open Sci. 2020 Nov 18;4:26-31. doi: 10.1016/j.sopen.2020.11.003. eCollection 2021 Apr. PMID: 33937740; PMCID: PMC8074785.
Copy Download .nbib Format: NLM
National retrospective cohort study to identify risk factors for in-hospital 30-day lethality in laboratory-confirmed cases of influenza.

Revista clinica espanola

Murillo-Zamora E, Mendoza-Cano O, Delgado-Enciso I, Guzmán-Esquivel J, Olick JK, Vinitzky-Seroussi V, Levy D.
PMID: 33998492
Rev Clin Esp (Barc). 2021 Feb;221(2):76-85. doi: 10.1016/j.rceng.2020.05.013. Epub 2020 Dec 27.

OBJECTIVE: To identify factors associated with the risk of death in adolescent and adult inpatients with laboratory-positive (reverse-transcription polymerase chain reaction) influenza in Mexico during consecutive influenza seasons (2018-2020).METHODS: A retrospective cohort study used national surveillance system data, enrolling...

Cite
Murillo-Zamora E, Mendoza-Cano O, Delgado-Enciso I, et al. National retrospective cohort study to identify risk factors for in-hospital 30-day lethality in laboratory-confirmed cases of influenza. Rev Clin Esp (Barc). 2020;221(2):76-85doi: 10.1016/j.rceng.2020.05.013.
Murillo-Zamora, E., Mendoza-Cano, O., Delgado-Enciso, I., Guzmán-Esquivel, J., Olick, J. K., Vinitzky-Seroussi, V., & Levy, D. (2021). National retrospective cohort study to identify risk factors for in-hospital 30-day lethality in laboratory-confirmed cases of influenza. Revista clinica espanola, 221(2), 76-85. https://doi.org/10.1016/j.rceng.2020.05.013
Murillo-Zamora, E, et al. "National retrospective cohort study to identify risk factors for in-hospital 30-day lethality in laboratory-confirmed cases of influenza." Revista clinica espanola vol. 221,2 (2021): 76-85. doi: https://doi.org/10.1016/j.rceng.2020.05.013
Murillo-Zamora E, Mendoza-Cano O, Delgado-Enciso I, Guzmán-Esquivel J, Olick JK, Vinitzky-Seroussi V, Levy D. National retrospective cohort study to identify risk factors for in-hospital 30-day lethality in laboratory-confirmed cases of influenza. Rev Clin Esp (Barc). 2021 Feb;221(2):76-85. doi: 10.1016/j.rceng.2020.05.013. Epub 2020 Dec 27. PMID: 33998492.
Copy Download .nbib Format: NLM
Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study.

Paediatrics & child health

Bélanger SA, Vanasse M, Spahis S, Sylvestre MP, Lippé S, L'heureux F, Ghadirian P, Vanasse CM, Levy E.
PMID: 19436468
Paediatr Child Health. 2009 Feb;14(2):89-98. doi: 10.1093/pch/14.2.89.

BACKGROUND: Although several clinical trials have evaluated the impact of n-3 polyunsaturated fatty acid (PUFA) on patients with attention-deficit hyperactivity disorder (ADHD), changes in plasma PUFA composition were not always assessed following n-3 supplementation. Furthermore, no reports are available...

Cite
Bélanger SA, Vanasse M, Spahis S, et al. Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study. Paediatr Child Health. 2009;14(2):89-98doi: 10.1093/pch/14.2.89.
Bélanger, S. A., Vanasse, M., Spahis, S., Sylvestre, M. P., Lippé, S., L'heureux, F., Ghadirian, P., Vanasse, C. M., & Levy, E. (2009). Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study. Paediatrics & child health, 14(2), 89-98. https://doi.org/10.1093/pch/14.2.89
Bélanger, Stacey Ageranioti, et al. "Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study." Paediatrics & child health vol. 14,2 (2009): 89-98. doi: https://doi.org/10.1093/pch/14.2.89
Bélanger SA, Vanasse M, Spahis S, Sylvestre MP, Lippé S, L'heureux F, Ghadirian P, Vanasse CM, Levy E. Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study. Paediatr Child Health. 2009 Feb;14(2):89-98. doi: 10.1093/pch/14.2.89. PMID: 19436468; PMCID: PMC2661342.
Copy Download .nbib Format: NLM
Heparin-induced Thrombocytopenia: Perioperative Diagnosis and Management.

Anesthesiology

Koster A, Nagler M, Erdoes G, Levy JH.
PMID: 34910815
Anesthesiology. 2022 Feb 01;136(2):336-344. doi: 10.1097/ALN.0000000000004090.

No abstract available.

Cite
Koster A, Nagler M, Erdoes G, et al. Heparin-induced Thrombocytopenia: Perioperative Diagnosis and Management. Anesthesiology. 2022;136(2):336-344doi: 10.1097/ALN.0000000000004090.
Koster, A., Nagler, M., Erdoes, G., & Levy, J. H. (2022). Heparin-induced Thrombocytopenia: Perioperative Diagnosis and Management. Anesthesiology, 136(2), 336-344. https://doi.org/10.1097/ALN.0000000000004090
Koster, Andreas, et al. "Heparin-induced Thrombocytopenia: Perioperative Diagnosis and Management." Anesthesiology vol. 136,2 (2022): 336-344. doi: https://doi.org/10.1097/ALN.0000000000004090
Koster A, Nagler M, Erdoes G, Levy JH. Heparin-induced Thrombocytopenia: Perioperative Diagnosis and Management. Anesthesiology. 2022 Feb 01;136(2):336-344. doi: 10.1097/ALN.0000000000004090. PMID: 34910815.
Copy Download .nbib Format: NLM
Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients.

Frontiers in immunology

Teixeira PC, Ducret A, Langen H, Nogoceke E, Santos RHB, Silva Nunes JP, Benvenuti L, Levy D, Bydlowski SP, Bocchi EA, Kuramoto Takara A, Fiorelli AI, Stolf NA, Pomeranzeff P, Chevillard C, Kalil J, Cunha-Neto E.
PMID: 34867990
Front Immunol. 2021 Nov 12;12:755782. doi: 10.3389/fimmu.2021.755782. eCollection 2021.

Chagas disease cardiomyopathy (CCC) is an inflammatory dilated cardiomyopathy occurring in 30% of the 6 million infected with the protozoan

Cite
Teixeira PC, Ducret A, Langen H, et al. Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients. Front Immunol. 2021;12:755782doi: 10.3389/fimmu.2021.755782.
Teixeira, P. C., Ducret, A., Langen, H., Nogoceke, E., Santos, R. H. B., Silva Nunes, J. P., Benvenuti, L., Levy, D., Bydlowski, S. P., Bocchi, E. A., Kuramoto Takara, A., Fiorelli, A. I., Stolf, N. A., Pomeranzeff, P., Chevillard, C., Kalil, J., & Cunha-Neto, E. (2021). Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients. Frontiers in immunology, 12755782. https://doi.org/10.3389/fimmu.2021.755782
Teixeira, Priscila Camillo, et al. "Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients." Frontiers in immunology vol. 12 (2021): 755782. doi: https://doi.org/10.3389/fimmu.2021.755782
Teixeira PC, Ducret A, Langen H, Nogoceke E, Santos RHB, Silva Nunes JP, Benvenuti L, Levy D, Bydlowski SP, Bocchi EA, Kuramoto Takara A, Fiorelli AI, Stolf NA, Pomeranzeff P, Chevillard C, Kalil J, Cunha-Neto E. Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients. Front Immunol. 2021 Nov 12;12:755782. doi: 10.3389/fimmu.2021.755782. eCollection 2021. PMID: 34867990; PMCID: PMC8633876.
Copy Download .nbib Format: NLM
Standard CMOS Fabrication of a Sensitive Fully Depleted Electrolyte-Insulator-Semiconductor Field Effect Transistor for Biosensor Applications.

Sensors (Basel, Switzerland)

Shalev G, Cohen A, Doron A, Machauf A, Horesh M, Virobnik U, Ullien D, Levy I.
PMID: 22408530
Sensors (Basel). 2009;9(6):4366-79. doi: 10.3390/s90604366. Epub 2009 Jun 04.

Microfabricated semiconductor devices are becoming increasingly relevant for detection of biological and chemical components. The integration of active biological materials together with sensitive transducers offers the possibility of generating highly sensitive, specific, selective and reliable biosensors. This paper presents...

Cite
Shalev G, Cohen A, Doron A, et al. Standard CMOS Fabrication of a Sensitive Fully Depleted Electrolyte-Insulator-Semiconductor Field Effect Transistor for Biosensor Applications. Sensors (Basel). 2009;9(6):4366-79doi: 10.3390/s90604366.
Shalev, G., Cohen, A., Doron, A., Machauf, A., Horesh, M., Virobnik, U., Ullien, D., & Levy, I. (2009). Standard CMOS Fabrication of a Sensitive Fully Depleted Electrolyte-Insulator-Semiconductor Field Effect Transistor for Biosensor Applications. Sensors (Basel, Switzerland), 9(6), 4366-79. https://doi.org/10.3390/s90604366
Shalev, Gil, et al. "Standard CMOS Fabrication of a Sensitive Fully Depleted Electrolyte-Insulator-Semiconductor Field Effect Transistor for Biosensor Applications." Sensors (Basel, Switzerland) vol. 9,6 (2009): 4366-79. doi: https://doi.org/10.3390/s90604366
Shalev G, Cohen A, Doron A, Machauf A, Horesh M, Virobnik U, Ullien D, Levy I. Standard CMOS Fabrication of a Sensitive Fully Depleted Electrolyte-Insulator-Semiconductor Field Effect Transistor for Biosensor Applications. Sensors (Basel). 2009;9(6):4366-79. doi: 10.3390/s90604366. Epub 2009 Jun 04. PMID: 22408530; PMCID: PMC3291915.
Copy Download .nbib Format: NLM
Lability criteria in diffusive gradients in thin films.

The journal of physical chemistry. A

Puy J, Uribe R, Mongin S, Galceran J, Cecília J, Levy J, Zhang H, Davison W.
PMID: 22404162
J Phys Chem A. 2012 Jun 28;116(25):6564-73. doi: 10.1021/jp212629z. Epub 2012 Mar 27.

The penetration of metal complexes into the resin layer of DGT (diffusive gradients in thin films) devices greatly influences the measured metal accumulation, unless the complexes are either totally inert or perfectly labile. Lability criteria to predict the contribution...

Cite
Puy J, Uribe R, Mongin S, et al. Lability criteria in diffusive gradients in thin films. J Phys Chem A. 2012;116(25):6564-73doi: 10.1021/jp212629z.
Puy, J., Uribe, R., Mongin, S., Galceran, J., Cecília, J., Levy, J., Zhang, H., & Davison, W. (2012). Lability criteria in diffusive gradients in thin films. The journal of physical chemistry. A, 116(25), 6564-73. https://doi.org/10.1021/jp212629z
Puy, Jaume, et al. "Lability criteria in diffusive gradients in thin films." The journal of physical chemistry. A vol. 116,25 (2012): 6564-73. doi: https://doi.org/10.1021/jp212629z
Puy J, Uribe R, Mongin S, Galceran J, Cecília J, Levy J, Zhang H, Davison W. Lability criteria in diffusive gradients in thin films. J Phys Chem A. 2012 Jun 28;116(25):6564-73. doi: 10.1021/jp212629z. Epub 2012 Mar 27. PMID: 22404162.
Copy Download .nbib Format: NLM
GOTMEDS? DESIGNING AND PILOTING AN INTERACTIVE MODULE FOR TRAINEES ON REDUCING DRUG COSTS.

Farnan JM, Arora V, Kumar R, Levy A, Shah N.
UIID-AD: 1247
2013;28.

No abstract available.

Cite
Farnan JM, Arora V, Kumar R, et al. GOTMEDS? DESIGNING AND PILOTING AN INTERACTIVE MODULE FOR TRAINEES ON REDUCING DRUG COSTS. 2013;28
Farnan, J. M., Arora, V., Kumar, R., Levy, A., & Shah, N. (2013). GOTMEDS? DESIGNING AND PILOTING AN INTERACTIVE MODULE FOR TRAINEES ON REDUCING DRUG COSTS. 28.
Farnan, J M, et al. "GOTMEDS? DESIGNING AND PILOTING AN INTERACTIVE MODULE FOR TRAINEES ON REDUCING DRUG COSTS." vol. 28 (2013).
Farnan JM, Arora V, Kumar R, Levy A, Shah N. GOTMEDS? DESIGNING AND PILOTING AN INTERACTIVE MODULE FOR TRAINEES ON REDUCING DRUG COSTS. 2013;28. UIID-AD: 1247.
Copy Download .nbib Format: NLM
Showing 1705 to 1715 of 1715 entries